Advances and challenges in gene therapies (part 1)
Tuesday, September 13, 2022
PLENARY
•
13-PM-PLENARY
•
3:00 PM
>
4:00 PM
•
Advances and challenges in gene therapies (part 1)
•
Apollon Auditorium
3:00 PM
•
S6L1
•
Challenges of AAV Gene Therapy Development for Duchenne Muscular Dystrophy
>
F.
Francesco
MUNTONI (London, Uk)
3:20 PM
•
S6L2
•
The management of safety of gene therapy of neuromuscular diseases, an emblematic example
>
S.
Serge
BRAUN (Evry, France)
3:40 PM
•
S6L3
•
The liver as a model tissue to develop innovative solutions to the existing limitations of AAV gene therapy
>
G.
Giuseppe
RONZITTI (Evry, France)
|